In 2013, I wrote about Sally K. Laden — the ghostwriter GSK paid big money to turn their failed Paxil study on children into a big fat “safe and effective” lie.
Part I shows exactly who Laden is. She’s got pharmacy degrees but worked as a hired pen for drug companies.
GSK only gave her a watered-down summary of the study and not the full scary details. Yet in December 1998 she happily wrote the first draft saying: “Paroxetine [Paxil] is a safe and effective treatment of depression in the adolescent patient.”
The study had actually failed. GSK insiders were privately panicking about the bad results and how to spin them so it didn’t hurt sales. But when lawyers questioned her years later, Laden suddenly couldn’t remember much. “I don’t recall” was her favourite answer.
Read Part I here:
https://t.co/q8c1MUMlE6
Part II is the really nasty bit. Kids on Paxil were having suicide attempts, but they hid it by calling it “emotional lability” — basically a fancy medical way of saying the kids were getting dangerously unstable. Laden used that phrase in her draft without any problem.
When lawyers showed her the real numbers (way more kids on Paxil tried to kill themselves than on placebo), she just shrugged and said “I’m not an expert.”
Not an expert? She had pharmacy degrees. She's a mum. She helped write the paper that doctors read.
What if it had been her own child they were giving this drug to?
Read Part II here:
https://t.co/tu1BSNG2yI
Bottom line: This was straight-up dirty ghostwriting. GSK and people like Sally Laden helped push a dangerous drug onto depressed kids while burying the suicide risks. The fake positive paper is still out there today.
Nobody’s retracted it.
Complicit. Plain and simple.
Mid-20th century idea: "Depression = faulty brain circuits, so cut the frontal lobes with a lobotomy."
Old idea: "Depression = low serotonin, so take a pill to fix the chemical imbalance."
New idea: "Depression = higher levels of inflammation, so take a pill to fix the inflammation."
Whatever next?
Future idea: "Depression = eyebrow dandruff sprinkling sad dust into your eyes, so take a pill to cure the dandruff the shampoo can't fix."
Honestly, they are running out of ideas.
SSRI victim speaks = psychiatry X account either denies harm exists or admits a tiny bit then screams "safe & effective!"
Not protecting patients.
Protecting the prescription pad and the comforting lie they tell themselves every day.
Your feelings are only valid for billing purposes.
Huge respect to Andri Rennwald, Michael Hengartner and Mark Horowitz for this important new study.
Finally, solid evidence showing the majority of "relapse" during antidepressant tapering is actually withdrawal and not the underlying condition returning.
These researchers keep shining a light on the inconvenient truth Big Pharma and their psychiatric cheerleaders have tried to bury for years.
This study contradicts the position of many prescribers who are led to believe that patients enjoy a normal, "depression free" life, but those abandoning the drug would suffer relapse back into a depressive state.
This stance was, in the main, created by drug companies in efforts to keep more people on their products disguising withdrawal as 'relapse'. (See Yugoslavia paroxetine (Seroxat UK, Paxil US) trial - 1998)
I fully anticipate more pushback from the pro-brain pellet brigade.
https://t.co/9vi2gF8LxG
A “Dr” who’s clocked up 10 years on probation (self-medicating with drug samples during a psychotic breakdown and failing to keep adequate medical records) now lecturing the unwashed masses about their "anti-medication" mentality.
“The other issue is this anti-medication mentality. It’s really bad out there. Um, you know, people getting advice from Doctor Google. Um, it’s very fashionable to be anti-medication.”
Psychiatrist Dr. Paul Corona disparages those raising awareness of psychiatric drug harms.
Your Tigo ads on X claim that you will be showing every World Cup game. Will the current outage be rectified in Chiriqui before June 12 or is Mas Movil or Starlink a better option?
In 2002, pharmaceutical giant GlaxoSmithKline (GSK) began funding therapy sessions for patients taking its antidepressant Aropax (more commonly known outside of Australia as Paxil or Seroxat), which was then the second most widely prescribed antidepressant in Australia.
Patients using Aropax could opt into a program called "APlus." The program offered five 90-minute group sessions of cognitive behavioral therapy over a two-month period, with groups of up to 14 patients.
GSK recruited psychologists, psychiatrists, and GPs across Australia to run the sessions. Their contracts required them to agree that “Adherence to (Aropax) was to be encouraged at all times.”
In 2012, I received additional information about the APlus Project.
Since then, every trace of it has mysteriously vanished from the internet.
Here’s what I learned.
https://t.co/xMHshPpfZh
Hardly surprising.
I posted this video 14 years ago.
It's pretty much how it all started down under.
How GlaxoSmithKline Australia promoted Aropax with starter packs and the offer of FREE counselling sessions...on the proviso that you continued taking Aropax!
Aropax, if you don't know, is the brand name for paroxetine, also known as Seroxat and Paxil.
https://t.co/ZZ1LAmSAX9
Australia’s soaring antidepressant use is forcing an overdue reckoning with the serotonin myth, overprescribing and the medicalisation of ordinary human distress.
The serotonin myth and the medicating of Australia
~ Professor Vince Hooper
https://t.co/eGY8erZA6e
Hardly surprising.
I posted this video 14 years ago.
It's pretty much how it all started down under.
How GlaxoSmithKline Australia promoted Aropax with starter packs and the offer of FREE counselling sessions...on the proviso that you continued taking Aropax!
Aropax, if you don't know, is the brand name for paroxetine, also known as Seroxat and Paxil.
https://t.co/ZZ1LAmSAX9
Akron families get a "youth mental health & suicide prevention" symposium courtesy of NAMI Summit County.
Funny how the same group taking sponsorship cash from Neurocrine Biosciences (psych drug makers) is now "helping" our kids talk about their struggles.
Nothing to see here, folks. Just keep popping the pills.
https://t.co/I9YU2xVjhr
Has Robbie Howard read this yet?
'Increased risk of death' warning for some people who use Sertraline, Citalopram and Fluoxetine
https://t.co/zKKQya0JBm
There's a lot to go through here.
I've picked out 5 of the 10. I recommend you read them all and not just the five I've covered below.
10 Misconceptions About Antidepressants, Debunked
1. Myth: Antidepressants Will ‘Change Your Personality’
Article says: They help you feel more like yourself. Any emotional blunting is just a manageable side effect, not a real personality change.
Nice try. They flatten emotions, turn people into zombies who can’t cry or feel joy, then call it 'finding yourself.' Many, myself for one, don’t recognise the stranger in the mirror looking back at them.
2. Myth: You’ll Be Hooked on Antidepressants for Life
Article says: Not addictive like opioids, no cravings. Just taper slowly because the brain adapts. Long-term use is like asthma meds.
Call it 'discontinuation syndrome' all you want. Brain zaps, dizziness, and hellish symptoms scream withdrawal. Perfect excuse for lifelong customers. Don't even get me started on the asthma meds comparison.
7. Myth: Antidepressants Will Always Ruin Your Sex Life
Article says: Common in about 50% of users, but not inevitable. Can improve once depression lifts.
Half of users get dead libido, delayed orgasm or genital numbness (PSSD). Many relationships are quietly destroyed in the bedroom. It does not improve and it's not depression!
8. Myth: You Can Stop Taking Antidepressants as Soon as You Feel Better
Article says: Stay on them 6-12 months minimum. Taper slowly or risk relapse.
Withdrawal symptoms are routinely mistaken for relapse. They create the dependency, then lecture you about not quitting too soon.
10. Myth: Antidepressants Increase the Risk of Suicide in Everyone
Article says: Federal agencies require a black box warning on antidepressant packaging about the increased risk of suicidal thoughts and behaviors. This warning focuses on children, teens, and young adults, especially early in treatment. Studies showed the risk was 4% on medication versus 2% on placebo.
They love waving around that comforting '4% versus 2%' stat like it’s a minor inconvenience . Only double the risk, folks! - Wow! Aren't we the lucky ones!
The article was reviewed by Angela D. Harper, MD, a psychiatrist.
Read the full 10 'Myths' here
https://t.co/szIyFITLcP